ProQR Therapeutics N.V.

NASDAQ: PRQR · Real-Time Price · USD
2.04
0.02 (0.99%)
At close: Aug 15, 2025, 3:59 PM
2.05
0.24%
After-hours: Aug 15, 2025, 04:10 PM EDT

ProQR Therapeutics Cash Flow Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-27.76M -27.54M -64.89M -61.68M
Depreciation & Amortization
2.76M 2.46M 2.52M 2.33M
Stock-Based Compensation
2.54M 3.11M 2.87M 6.22M
Other Working Capital
-13.26M 48.96M -4.99M 25.01M
Other Non-Cash Items
-474K -5.35M -3.67M 2.01M
Deferred Income Tax
-197K -78K 96K 117K
Change in Working Capital
-13.26M 48.96M -4.99M 25M
Operating Cash Flow
-36.39M 21.55M -68.51M -26.01M
Capital Expenditures
-1.42M -1.37M -708K -484K
Cash Acquisitions
n/a 58.77K 5.89K 61.35K
Purchase of Investments
-17M n/a n/a n/a
Sales Maturities Of Investments
17M n/a n/a n/a
Other Investing Acitivies
-2.65M 7.86M 6K -2.35K
Investing Cash Flow
-4.07M 4.28M -702K -425K
Debt Repayment
-1.58M -2.63M -45.05M 26.84M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
223K 354K 34K 1.52M
Financial Cash Flow
70.28M -2.27M -30.89M 136.83M
Net Cash Flow
30.48M 24.15M -92.75M 111.69M
Free Cash Flow
-37.81M 20.18M -69.22M -26.5M